AU Patent

AU2024336235A1 — Pharmaceutical composition with enhanced properties, method for preparation, and use thereof

Assigned to Foresee Pharmaceuticals USA Inc · Expires 2026-03-19 · 0y expired

What this patent protects

The present application relates to compositions and methods in preparation of spray dried amorphous solid dispersion comprising 5-{3-[4-(3-methyl-benzyloxy) phenylthio]fur-2-yl}imidazolidine-2, 4-dione and hydroxypropyl beta-cyclodextrin. In particular, the present application re…

USPTO Abstract

The present application relates to compositions and methods in preparation of spray dried amorphous solid dispersion comprising 5-{3-[4-(3-methyl-benzyloxy) phenylthio]fur-2-yl}imidazolidine-2, 4-dione and hydroxypropyl beta-cyclodextrin. In particular, the present application relates to an improved spray drying method for producing amorphous solid dispersions with enhanced properties by the use of a co-solvent system and/or an antioxidant.

Drugs covered by this patent

Patent Metadata

Patent number
AU2024336235A1
Jurisdiction
AU
Classification
—
Expires
2026-03-19
Drug substance claim
No
Drug product claim
No
Assignee
Foresee Pharmaceuticals USA Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.